UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma

Frontiers in oncology, 2019-08, Vol.9, p.815-815

2019

Volltextzugriff (PDF)

Genomic analysis of metastatic cutaneous squamous cell carcinoma

Clinical cancer research, 2015-03, Vol.21 (6), p.1447-1456

2015

Volltextzugriff (PDF)

Management of elderly patients with locoregionally confined head and neck cancer

The lancet oncology, 2017-05, Vol.18 (5), p.e274-e283

2017

Volltextzugriff (PDF)

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck

Cancer, 2016-12, Vol.122 (23), p.3632-3640

2016

Volltextzugriff (PDF)

Marital status and head and neck cancer outcomes

Cancer, 2015-04, Vol.121 (8), p.1273-1278

2015

Volltextzugriff (PDF)

Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer

The New England journal of medicine, 2014-10, Vol.371 (15), p.1426-1433

2014

Volltextzugriff (PDF)

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

Oral oncology, 2012-11, Vol.48 (11), p.1085-1089

2012

Volltextzugriff (PDF)

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

The lancet oncology, 2011-02, Vol.12 (2), p.153-159

2011

Volltextzugriff (PDF)

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Oral oncology, 2021-08, Vol.119, p.105366-105366, Article 105366

2021

Volltextzugriff (PDF)

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2013-08, Vol.73 (16), p.5195-5205

2013

Volltextzugriff (PDF)

Trastuzumab for the Treatment of Salivary Duct Carcinoma

The oncologist (Dayton, Ohio), 2013-03, Vol.18 (3), p.294-300

2013

Volltextzugriff (PDF)

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

Oral oncology, 2019-08, Vol.95, p.120-126

2019

Volltextzugriff (PDF)

Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer

Cancer prevention research (Philadelphia, Pa.), 2019-10, Vol.12 (10), p.689-700

2019

Volltextzugriff (PDF)

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma

Oral oncology, 2020-07, Vol.106, p.104690, Article 104690

2020

Volltextzugriff (PDF)

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003026

2022

Volltextzugriff (PDF)

Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

International journal of radiation oncology, biology, physics, 2008-11, Vol.72 (4), p.1110-1118

2008

Volltextzugriff (PDF)

The Benefits of Adjuvant Trastuzumab for HER‐2‐Positive Salivary Gland Cancers

The oncologist (Dayton, Ohio), 2020-07, Vol.25 (7), p.598-608

2020

Volltextzugriff (PDF)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer

British journal of cancer, 2016-07, Vol.115 (2), p.252-260

2016

Volltextzugriff (PDF)

Head and neck cancer

The Lancet (British edition), 2021-12, Vol.398 (10318), p.2289-2299

2021

Volltextzugriff (PDF)

Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension

European radiology, 2023-05, Vol.33 (5), p.3693-3703

2023

Volltextzugriff (PDF)

Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (19), p.5004-5013

2012

Volltextzugriff (PDF)

Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma

Journal of translational medicine, 2024-10, Vol.22 (1), p.960-13, Article 960

2024

Volltextzugriff (PDF)

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients

Cancer prevention research (Philadelphia, Pa.), 2009-09, Vol.2 (9), p.776-781

2009

Volltextzugriff (PDF)

1 – 25 von 1.552

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.357)
Mit Volltextzugriff
(1.301)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(21)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma

Genomic analysis of metastatic cutaneous squamous cell carcinoma

Management of elderly patients with locoregionally confined head and neck cancer

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck

Marital status and head and neck cancer outcomes

Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma

Trastuzumab for the Treatment of Salivary Duct Carcinoma

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

The Benefits of Adjuvant Trastuzumab for HER‐2‐Positive Salivary Gland Cancers

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer

Head and neck cancer

Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension

Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma

Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients

Aktive Filter

Suchergebnisse filtern